| COPAD | cyclophosphamide, vincristine, Adriamycin, prednisone, cytarabine, asparagine, intrathecal methotrex... |
|---|---|
| Cy | cyanogen; cyclophosphamide; cyst; cytarabine |
| HDARAC | high dose cytarabine (ARA C) |
| cytarabine | <drug, oncology> A pyrimidine nucleoside analog that is used mainly in the treatment of leukaemia, especially acute non-lymphoblastic leukaemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the s phase of the cell cycle. It also has antiviral and immunosuppressant properties. Pharmacological action: antimetabolite, antineoplastic, antiviral agent, immunosuppressive agent. Chemical name: 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl- (12 Dec 1998) |
|---|
Synonyms : Aracytidine, Aracytine, Cytarabine Hydrochloride, Cytonal, Cytosar, Cytosar-U, beta-Ara C, Arabinoside, Cytosine, Cytosar U, CytosarU, Hydrochloride, Cytarabine
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
타빈주 - 새창
|
한국유나이티드제약 |
A12900311 | Cytarabine | 전문의약품 | 삭제 | 분업예외의약품 |
|
중외시타라빈주40mg/2ml - 새창
|
중외 |
A02102511 | Cytarabine | 전문의약품 | 급여 | 분업예외의약품 |
|
중외시타라빈바이알주사액500mg - 새창
|
중외 |
A02105411 | Cytarabine | 전문의약품 | 급여 | 분업예외의약품 |
|
싸이토사유주사100mg - 새창
|
Pharmacia |
E00750021 | Cytarabine | 전문의약품 | 삭제 |
|
타빈주20mg/ml - 새창
|
한국유나이티드제약 |
A12941051 | Cytarabine | 전문의약품 | 삭제 |
|
싸이토사유주사1g - 새창
|
Pharmacia |
W00130121 | Cytarabine | 전문의약품 | 삭제 |
|
타빈주50mg/ml - 새창
|
한국유나이티드제약 |
A12941231 | Cytarabine | 전문의약품 | 삭제 | 분업예외의약품 |
|
트라빈주100mg - 새창
|
한국유니온제약 |
A12253681 | Cytarabine | 전문의약품 | 급여 |
|
싸이토사유100mg - 새창
|
한국화이자 |
W21890151 | Cytarabine | 전문의약품 | 급여 |
|
에베베시타라빈주50mg/ml(20ml) - 새창
|
삼오제약 |
W26080101 | Cytarabine | 전문의약품 | 급여 |
| cytarabine |
An anticancer drug that belongs to the family of drugs called antimetabolites.
출처: www.spineuniverse.com/community/cancerdictionary.h...
|
|---|---|
| cytarabine liposome i. |
liposomal cytarabine.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|